Yen Hung-Wen, Yang Wu-Chang, Tarng Der-Cherng, Yang Chih-Yu, Chuang Chiao-Lin, Huang Ling-Ju, Lin Pei-Yu, Wang Chih-Chun, Li Szu-Yuan
Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Hemodial Int. 2016 Apr;20(2):315-20. doi: 10.1111/hdi.12378. Epub 2015 Nov 9.
Catheter-related blood stream infection (CRBSI) is a major complication in hemodialysis patients. We assessed the efficacy of systemic daptomycin (DPT) plus DPT antibiotic lock therapy (DPT-ALT) for catheter salvage in patients with Gram-positive CRBSIs. This is a retrospective study of hemodialysis patients with tunneled and cuffed hemodialysis catheters. All patients were from a single institution in Taipei and received systemic DPT plus DPT-ALT for the treatment of Gram-positive CRBSI. Successful resolution of CRBSI was implemented. Resolution of fever within 48 hours, negative result of repeated blood cultures after resolution of fever, no clinical evidence of CRBSI relapse and no need for catheter removal were measured. Fifteen hemodialysis patients received DPT-ALT for CRBSI, nine with coagulase-negative Staphylococcus (CONS), two with methicillin-resistant Staphylococcus aureus (MRSA), three with methicillin-sensitive Staphylococcus aureus (MSSA) and one with polymicrobial infections. Systemic DPT plus DPT-ALT cured 11 patients (73.3%). Treatment failed in all three MRSA cases (two with MRSA and one with MRSA + Enterococcus faecalis). Retrospective design and small sample size were the limitations of this study. Systemic DPT plus DPT-ALT appears to be a promising treatment for CRBSI from CONS and MSSA, but not for MRSA CRBSI. Systemic DPT plus DPT-ALT should be considered for patients with CRBSIs caused by certain species.
导管相关血流感染(CRBSI)是血液透析患者的一种主要并发症。我们评估了全身应用达托霉素(DPT)加DPT抗生素封管疗法(DPT-ALT)对革兰氏阳性CRBSI患者导管挽救的疗效。这是一项对带隧道涤纶套血液透析导管患者的回顾性研究。所有患者均来自台北的一家机构,接受全身DPT加DPT-ALT治疗革兰氏阳性CRBSI。实现了CRBSI的成功解决。测量了48小时内发热的消退情况、发热消退后重复血培养的阴性结果、无CRBSI复发的临床证据以及无需拔除导管的情况。15例血液透析患者因CRBSI接受了DPT-ALT治疗,其中9例为凝固酶阴性葡萄球菌(CONS)感染,2例为耐甲氧西林金黄色葡萄球菌(MRSA)感染,3例为甲氧西林敏感金黄色葡萄球菌(MSSA)感染,1例为混合菌感染。全身DPT加DPT-ALT治愈了11例患者(73.3%)。所有3例MRSA病例(2例为MRSA感染,1例为MRSA + 粪肠球菌感染)治疗均失败。回顾性设计和小样本量是本研究的局限性。全身DPT加DPT-ALT似乎是治疗CONS和MSSA引起的CRBSI的一种有前景的疗法,但对MRSA引起的CRBSI无效。对于某些菌种引起的CRBSI患者,应考虑全身应用DPT加DPT-ALT。